Skip to main content
. 2013 Mar 7;5(3):725–749. doi: 10.3390/nu5030725

Figure 8.

Figure 8

MSA decreases tumor growth of human melanoma in vivo. (a) Treatment of Nod/SCID mice bearing Lox melanoma xenograft tumors with oral MSA (1.25 mg Se/kg daily) decreases tumor weights (p = 0.0007) and (b) reduces SPARC levels in tumors (p = 0.067).